Buyline Blog

HEALTHCARE INDUSTRY INFORMATION AND INSIGHT FROM MD BUYLINE EXPERT ANALYSTS

Posts Tagged ‘MRI’

Vascular Brain Injury Could Play an Important Role In Predicting Cognitive Impairment

By
March 5, 2013

New research, published in JAMA Neurology by Dr. Bruce Reed and colleagues, has found that vascular brain injury, resulting from high blood pressure or stroke, might be more significant at predicting cognitive impairment than amyloid plaque formation, which is traditionally associated with Alzheimer’s and other forms of dementia. Read More »

Happy National Radiologic Technology Week!

By
November 6, 2012

MD Buyline thanks medical imaging professionals everywhere during National Radiologic Technology Week (NRTW) which runs from November 4-10. Originally the [...] Read More »

Multimodality Imaging Approaches: PET/CT vs. PET/MR

By
September 13, 2012

For many years PET/CT has been the preferred imaging method for the diagnosis, staging and restaging of malignant diseases and [...] Read More »

A Great Debate: What Type of Fluoroscopy System Will Suit My Needs?

By
August 21, 2012

The global awareness and proactive reduction of radiation exposure from radiologic procedures has been a pretty hot topic in healthcare [...] Read More »

Medical Imaging at the 2012 Summer Olympics

By
July 31, 2012

In my life before MD Buyline, I gained experience in Sports Medicine X-rays while working as a contracted radiographer at an NFL stadium in the late 90s; so I knew that medical imaging would be readily available to the Olympic athletes to some degree. However, after brushing up on a few updates and press releases, I found out that the depth and breadth of imaging modalities located in London’s Polyclinics today, which are provided by GE Healthcare, are a far cry from the portable X-ray unit, film processor and view box I used sixteen years ago during the Atlanta Falcons’ home games. Despite this, the goal has remained the same: get the medical imaging procedure done quickly and accurately, get the results to the right people and get the athlete back in the game if the results support that decision. Read More »

Quicker and Lower Cost Lab Technology

By
September 13, 2011

There is an emerging laboratory technology that is based on nuclear magnetic resonance and nanoparticles, and this combination offers the promise of identifying almost any protein, cancer, bacteria, or virus quickly at the molecular level and at a lower cost than existing technologies. One of the first target applications is Candida, a blood-borne infection with a mortality rate of 20%. Read More »

CMS Takes Aim at Overused Imaging

By
March 29, 2011

Imaging efficiency measures are part of the Measures Management System now being developed by CMS. Its goal is to ensure proper utilization of imaging technology and to guarantee that new proposed payment strategies are based on scientific evidence. The primary focus of the program is on high-cost PET, SPECT, ultrasound, MRI, and CT technologies. Read More »

Blood Test, then MRI = New Diagnostic Path for Breast Cancer

By
March 24, 2011

How good are breast cancer blood tests? Digital mammography has an accuracy rate for women under age 50 at 84%; film mammography, 69%. The published results for the BT test reflect 97% accuracy. For women over 50, digital mammography has an accuracy rate at 77%; film, 75%; BT, 86% accuracy. Read More »

Could 7T MRI Launch a New Technology Race?

By
January 5, 2011

Of course, 7T systems cost considerably more than a 3T. The question to ask is: what additional information will they offer? One study showed that the higher field strengths of 7T offer improved sensitivity and contrast when compared to 3T. With improved sensitivity, physicians are twice as likely to distinguish between multiple sclerosis (MS) brain lesions and normal white matter. Read More »

Real Real-Time Radiation Therapy, Really

By
November 8, 2010

Think about it – an MRI system and three gamma ray sources functioning together as a large robot, a solution that researchers have developed to hit a moving tumor that you can’t see. Sounds like a similar problem scientists faced with the Strategic Defense Initiative three decades ago, but it’s real today. Read More »